{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:36:34Z","timestamp":1777545394081,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ymgme.2008.01.014","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T01:50:57Z","timestamp":1205891457000},"page":"222-233","source":"Crossref","is-referenced-by-count":46,"title":["Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"94","author":[{"given":"David E.","family":"Sleat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukarram","family":"El-Banna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Sohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwi-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostantin","family":"Dobrenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven U.","family":"Walkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.01.014_bib1","series-title":"Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Goebel","year":"1999"},{"key":"10.1016\/j.ymgme.2008.01.014_bib2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2008.01.014_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0167-4838(98)00238-6","article-title":"Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis","volume":"1429","author":"Rawlings","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2008.01.014_bib4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/302427","article-title":"Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder","volume":"64","author":"Sleat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2008.01.014_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1012419823739","article-title":"Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?","volume":"24","author":"Maire","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.01.014_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib7","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1089\/hum.2005.16.1484","article-title":"Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates","volume":"16","author":"Hackett","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.gt.3301843","article-title":"Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system","volume":"10","author":"Haskell","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib9","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2008.01.014_bib10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2008.01.014_bib11","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8","article-title":"Expression of cre recombinase in mouse oocytes: a means to study maternal effect genes","volume":"26","author":"de Vries","year":"2000","journal-title":"Genesis"},{"key":"10.1016\/j.ymgme.2008.01.014_bib14","doi-asserted-by":"crossref","first-page":"35436","DOI":"10.1074\/jbc.M606208200","article-title":"Demonstration of lysosomal localization for the mammalian ependymin-related protein using classical approaches combined with a novel density shift method","volume":"281","author":"Della Valle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.014_bib15","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1074\/jbc.M507336200","article-title":"Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates","volume":"281","author":"Tian","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.014_bib16","doi-asserted-by":"crossref","first-page":"19191","DOI":"10.1074\/jbc.271.32.19191","article-title":"Rat brain contains high levels of mannose-6-phosphorylated glycoproteins including lysosomal enzymes and palmitoyl-protein thioesterase, an enzyme implicated in infantile neuronal lipofuscinosis","volume":"271","author":"Sleat","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.014_bib17","series-title":"What\u2019s Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice","author":"Crawley","year":"2000"},{"key":"10.1016\/j.ymgme.2008.01.014_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/0264-6021:3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2008.01.014_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2006.11.006","article-title":"Lysosomal accumulation of SCMAS (subunit C of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B","volume":"90","author":"Ryazantsev","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.01.014_bib20","first-page":"211","article-title":"Lysosomal storage of the DCCD reactive proteolipid subunit of mitochondrial ATP synthase in human and ovine ceroid lipofuscinoses","volume":"266","author":"Palmer","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgme.2008.01.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","article-title":"New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy","volume":"121","author":"Beck","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.01.014_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease","volume":"88","author":"Leinekugel","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.01.014_bib23","doi-asserted-by":"crossref","first-page":"14982","DOI":"10.1073\/pnas.232570999","article-title":"Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis","volume":"99","author":"Tomatsu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.01.014_bib24","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2008.01.014_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2008.01.014_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1089\/hum.2005.16.1028","article-title":"Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders","volume":"16","author":"Arkin","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.01.014_bib27","first-page":"156","article-title":"HuCNS-SC (StemCells)","volume":"8","author":"Taupin","year":"2006","journal-title":"Curr. Opin. Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T17:53:28Z","timestamp":1546192408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1096719208000176"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.01.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}